Zobrazeno 1 - 10
of 881
pro vyhledávání: '"Byong-Duk Ye"'
Autor:
Sun Young Kim, Jinhyeon Kim, Hajung Kim, Young-Tae Chang, Hwa-Young Kwon, Jong Lyul Lee, Yong Sik Yoon, Chan Wook Kim, Seung-Mo Hong, Jin-ho Shin, Seung Wook Hong, Sung Wook Hwang, Byong Duk Ye, Jeong-Sik Byeon, Suk-Kyun Yang, Byung Ho Son, Seung-Jae Myung
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Fluorescence-guided surgery has emerged as an innovative technique with promising applications in the treatment of various tumors, including colon cancer. Tumor-initiating probe yellow (TiY) has been discovered for identifying tumorigenic ce
Externí odkaz:
https://doaj.org/article/c4d3bd942f6341eb8fc0d611fbc67c20
Autor:
Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We aimed to identify the safety and effectiveness of tofacitinib in patients with UC in routine clinical settings in Korea. Methods This o
Externí odkaz:
https://doaj.org/article/19716eccc3444a97adb85097b1a70de5
Autor:
June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
Publikováno v:
Gut and Liver, Vol 18, Iss 4, Pp 667-676 (2024)
Background/Aims: Studies on elective switching to the subcutaneous (SC) formulation of infliximab revealed comparable efficacy and safety and higher infliximab level than those exhibited by intravenous (IV) infliximab. However, no studies have report
Externí odkaz:
https://doaj.org/article/bbf733f92270470eb3c8de577f913947
Autor:
Tanita Suttichaimongkol, Sung Wook Hwang, Nayantara Coelho-Prabhu, John B. Kisiel, Byong Duk Ye, Suk-Kyun Yang, Edward V. Loftus, Sang Hyoung Park
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Crohn’s disease (CD) exhibits variability in colorectal cancer (CRC) incidence and prognostic factors due to diverse clinical and behavioral characteristics, presenting inconsistencies between Western and Eastern patients. Objectives: T
Externí odkaz:
https://doaj.org/article/2103dcb9a26142658fd8dc2e48d4651f
Autor:
Jongwook Yu, Sung Jae Shin, Yune-Jung Park, Hyung Wook Kim, Bo-In Lee, Byong Duk Ye, Geun-Tae Kim, Sung Kook Kim, Joo Sung Kim, Young-Ho Kim, Seonjeong Jeong, Jae Hee Cheon
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Intestinal Behçet’s disease (BD) is characterized by typical gastrointestinal ulcers in patients with BD followed by complications such as bleeding, perforation and fistula. Biologic agents are currently under active investigat
Externí odkaz:
https://doaj.org/article/9d039b74ea4c4de78b7af424d3b64c76
Autor:
Jing Chen, Ju-Young Shin, Sumitra Shantakumar, Sungho Bea, Byong Duk Ye, Dong-Gun Lee, Hyungwoo Kim, Won Suk Choi, Iain Kaan
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 12, Pp 2771-2790 (2023)
Abstract Introduction To estimate herpes zoster (HZ) incidence rate (IR) and economic burden in individuals with immunocompromised conditions and autoimmune diseases (IC/AID) in the Republic of Korea (ROK). Methods The nationwide Health Insurance Rev
Externí odkaz:
https://doaj.org/article/d12f6502a3e84d9fbfa991d4bdb0d2ff
Autor:
Min Kyu Kim, Su In Jo, Sang-Yeob Kim, Hyun Lim, Ho Suk Kang, Sung‑Hoon Moon, Byong Duk Ye, Jae Seung Soh, Sung Wook Hwang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Differentiating inflammatory bowel disease (IBD) from other inflammatory diseases is often challenging. Programmed cell death protein-1 (PD-1) is expressed in T cells and is an indicator of their exhaustion. The role of PD-1 expression in di
Externí odkaz:
https://doaj.org/article/1815b8a6fd0b47ac92b70e3184dd0993
Autor:
Hyuk Yoon, Young Soo Park, Jeong Eun Shin, Byong Duk Ye, Chang Soo Eun, Soon Man Yoon, Jae Myung Cha, You Sun Kim, Kyu Chan Huh, Young Sook Park, Jae Hee Cheon, Eun Suk Jung, Youngdoe Kim, Su Young Jung
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Many patients with ulcerative colitis (UC) gain weight after treatment. However, the clinical significance of weight gain in these patients remains unclear. This study aimed to evaluate body weight changes after treatment in patie
Externí odkaz:
https://doaj.org/article/fc66e354f39e4dbb8a2cda2140d54984
Autor:
Jae Hee Cheon, Hyun-Soo Kim, Dong Soo Han, Sung Kook Kim, Sung Jae Shin, Joo Sung Kim, Byong Duk Ye, Geun Am Song, YoungJa Lee, Youngdoe Kim, Yoosun Lee, Won Ho Kim, BEGIN Study Group
Publikováno v:
Gut and Liver, Vol 17, Iss 5, Pp 777-785 (2023)
Background/Aims: To date, there is no prospective study that specifically investigated the efficacy of infliximab in intestinal Behçet’s disease (BD). This study evaluated the efficacy of infliximab in patients with moderate-to-severe active intes
Externí odkaz:
https://doaj.org/article/d9ce82fab83c459abddb0226b5c1197a
Autor:
Seung Bum Lee, Hee Seung Hong, Chang Kyun Lee, Bo-In Lee, Sol Kim, Seong-Joon Koh, Hosun Yu, Jung-Bin Park, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 5, Pp 661-671 (2023)
Background/Aims The short- and long-term effects of adalimumab (ADA) on Korean patients with intestinal Behcet’s disease (BD) for remain unclear. Therefore, a multicenter study was performed to evaluate the efficacy and safety of ADA in Korean pati
Externí odkaz:
https://doaj.org/article/5366d33b6922447e95aa9c179de4df06